The Global Injectable Drug Delivery Market report published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc. According to the report the Global Injectable Drug Delivery Market is estimated to be USD 40.5 billion in 2016 and predicted to rise to USD 92.65 million by 2021 with a CAGR of 18.1%. The market is segmented by Device Type (Self-injection Devices, Conventional Devices), by Formulation (Conventional Drug Delivery, Novel Drug Delivery), by Therapeutic Use (Autoimmune Disorders, Hormonal Disorders, Oncology), by End-user Application (Hospitals, Homecare Settings, Research Institutes, Clinical Laboratories) Further the market is also geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa.
The key factors driving the Injectable Drug Delivery Market are Increased prevalence of chronic diseases, Technological advances in the form of nanotechnologies, Rising demand for biologics in the pharmaceutical industry and Increased patient compliance. The Restraining factors affecting the IDD market include Possibility of injuries and infections via usage, Product recalls, Emergence of alternative drug delivery systems, Regulatory framework concerns.
Injectable Drug Delivery Market was dominated by North America, with the overall market share of over 35% globally. North America was followed by Europe and Asia-Pacific. Asia Pacific is predicted to grow at a rapid pace in the coming few years.
Alkermes Inc., Bend Research, BIND Biosciences, Inc., Endocyte, Genentech Inc., MicroCHIPS, Inc., Pearl Therapeutics Inc., Polymer Factory, Presage Bioscience, QLT Inc., UCB Group.
Browse through the full report at “http://www.marketdataforecast.com/market-reports/global-injectable-drug-delivery-market-2108/” and checkout our recent reports in the Medical Devices category at “http://www.marketdataforecast.com/research-reports/healthcare/medical-devices-2/”. For more insights and up-to-date industry news don’t forget subscribing to our newsletters.